Brand Asset Management Group’s AstraZeneca AZN Stock Holding History

Brand Asset Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-57	Closed	-$5K	–	318
2019 Q1	$5K	Buy	+57	New	+$4.49K	﹤0.01%	274
2018 Q4	–	Sell	-411	Closed	-$32K	–	221
2018 Q3	$32K	Hold	411	–	–	0.02%	151
2018 Q2	$29K	Buy	+411	New	+$29.6K	0.02%	159

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brand Asset Management Group's AZN Position: Q2 2019 in Review

Brand Asset Management Group sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 57 shares — an estimated $5K sold.

Brand Asset Management Group first reported a position in AZN in Q2 2018 and held it in 3 quarters. The position peaked at $32K in Q3 2018. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Brand Asset Management Group reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
Brand Asset Management Group sold 57 AstraZeneca shares in Q2 2019, an estimated $5K.
Brand Asset Management Group first reported a position in AstraZeneca in Q2 2018 and held it in 3 quarters.
Brand Asset Management Group's AstraZeneca position peaked at $32K in Q3 2018.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Brand Asset Management Group's 13F filing for Q2 2019, filed 24 Jul 2019.